What is your experience with Pylarify vs. Posluma PSMA PET for prostate cancer and is one preferred over the other?

There is no definitive evidence at this time that one of these imaging agents is clearly superior to the other because there are no comparative data in the same patient group.

For Posluma, the potential benefit over Pylarify would be lower bladder excretion allowing for better visualization of the pelvic structures near the bladder and the ureters. Particularly, for evaluating the local site to accurately detect the location of recurrences - such as the seminal vesicles, vas deferens, and the pro...